U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C10H16N5O13P3
Molecular Weight 507.181
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of ZIDOVUDINE TRIPHOSPHATE

SMILES

CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O2)C(=O)NC1=O

InChI

InChIKey=GLWHPRRGGYLLRV-XLPZGREQSA-N
InChI=1S/C10H16N5O13P3/c1-5-3-15(10(17)12-9(5)16)8-2-6(13-14-11)7(26-8)4-25-30(21,22)28-31(23,24)27-29(18,19)20/h3,6-8H,2,4H2,1H3,(H,21,22)(H,23,24)(H,12,16,17)(H2,18,19,20)/t6-,7+,8+/m0/s1

HIDE SMILES / InChI

Molecular Formula C10H16N5O13P3
Molecular Weight 507.181
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 1
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
Human immunodeficiency virus reverse transcriptase. General properties and its interactions with nucleoside triphosphate analogs.
1987 Feb 15
Site-specific mutagenesis of AIDS virus reverse transcriptase.
1987 Jun 25-Jul 1
Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)].
1987 Mar
Inhibition of the reverse transcriptase from HIV by 3'-azido-3'-deoxythymidine triphosphate and its threo analogue.
1987 Mar
Inhibition of HIV-associated reverse transcriptase by sugar-modified derivatives of thymidine 5'-triphosphate in comparison to cellular DNA polymerases alpha and beta.
1987 Oct 14
Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro.
1988 Aug
Alpha, beta- and beta, gamma-methylene 5'-phosphonate derivatives of 3'-azido-2',3'-dideoxythymidine-5'-triphosphate. Correlation between affinity for reverse transcriptase, susceptibility to hydrolysis by phosphodiesterases and anti-retrovirus activity.
1988 Jun 15
Reverse transcriptases from human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus (SIVMAC) are susceptible to inhibition by foscarnet and 3'-azido-3'-deoxythymidine triphosphate.
1988 Nov
Azidothymidine triphosphate is an inhibitor of both human immunodeficiency virus type 1 reverse transcriptase and DNA polymerase gamma.
1989 Dec
A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine.
1989 Dec
Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative.
1989 Dec 29
1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine. A highly potent and selective anti-HIV agent.
1989 Feb
Comparison of inhibitory activities of various antiretroviral agents against particle-derived and recombinant human immunodeficiency virus type 1 reverse transcriptases.
1989 Jan
An analysis of the inhibition of replication of HIV and MuLV by some 3'-blocked pyrimidine analogs.
1989 Jan 1
Combinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro.
1989 May
Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnet.
1989 May
Differential inhibitory effects of several pyrimidine 2',3'-dideoxynucleoside 5'-triphosphates on the activities of reverse transcriptase and various cellular DNA polymerases.
1989 May
Phosphorylation of 3'-azido-2',3'-dideoxyuridine and preferential inhibition of human and simian immunodeficiency virus reverse transcriptases by its 5'-triphosphate.
1989 Oct
Synthesis and structure-activity relationships of 6-substituted 2',3'-dideoxypurine nucleosides as potential anti-human immunodeficiency virus agents.
1990 Jun
Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides.
1993 Apr
Diarylsulfones, a new chemical class of nonnucleoside antiviral inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
1993 Apr
Synthesis and virucidal activity of a water-soluble, configurationally stable, derivatized C60 fullerene.
1993 Aug
The 5'-triphosphates of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolane-5-yl]cytosine equally inhibit human immunodeficiency virus type 1 reverse transcriptase.
1993 Aug
Activity of a novel quinoxaline derivative against human immunodeficiency virus type 1 reverse transcriptase and viral replication.
1993 Aug
Viral resistance to the thiazolo-iso-indolinones, a new class of nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
1993 Dec
Lack of synergy in the inhibition of HIV-1 reverse transcriptase by combinations of the 5'-triphosphates of various anti-HIV nucleoside analogs.
1993 Dec
Identification of the amino acid in the human immunodeficiency virus type 1 reverse transcriptase involved in the pyrophosphate binding of antiviral nucleoside triphosphate analogs and phosphonoformate. Implications for multiple drug resistance.
1993 Dec 14
pol mutations conferring zidovudine and didanosine resistance with different effects in vitro yield multiply resistant human immunodeficiency virus type 1 isolates in vivo.
1993 Jul
Mechanism of resistance of human immunodeficiency virus type 1 to 2',3'-dideoxyinosine.
1993 Jul 1
U-90152, a potent inhibitor of human immunodeficiency virus type 1 replication.
1993 May
Synthesis and anti-HIV-1 activity of a series of imidazo[1,5-b]pyridazines.
1993 Nov 26
Selective and synergistic inhibition of human immunodeficiency virus type 1 reverse transcriptase by a non-nucleoside inhibitor, MKC-442.
1993 Oct
5-Chloro-2',3'-dideoxy-3'-fluorouridine (935U83), a selective anti-human immunodeficiency virus agent with an improved metabolic and toxicological profile.
1994 Jul
Inhibition of human immunodeficiency virus type 1 integrase by 3'-azido-3'-deoxythymidylate.
1994 Jun 21
Kinetic and mutational analysis of human immunodeficiency virus type 1 reverse transcriptase inhibition by inophyllums, a novel class of non-nucleoside inhibitors.
1994 Mar 4
The K65R mutant reverse transcriptase of HIV-1 cross-resistant to 2', 3'-dideoxycytidine, 2',3'-dideoxy-3'-thiacytidine, and 2',3'-dideoxyinosine shows reduced sensitivity to specific dideoxynucleoside triphosphate inhibitors in vitro.
1994 Nov 11
Inhibition of human immunodeficiency virus type 1 reverse transcriptase by the 5'-triphosphate beta enantiomers of cytidine analogs.
1994 Oct
Action of uracil analogs on human immunodeficiency virus type 1 and its reverse transcriptase.
1995 Feb
Thiadiazole derivatives: highly potent and specific HIV-1 reverse transcriptase inhibitors.
1995 Jun 9
Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
1995 Oct
Enzymatic characterization of human immunodeficiency virus type 1 reverse transcriptase resistant to multiple 2',3'-dideoxynucleoside 5'-triphosphates.
1995 Oct 6
Linked lexitropsins and the in vitro inhibition of HIV-1 reverse transcriptase RNA-directed DNA polymerization: a novel induced-fit of 3,5 m-pyridyl bisdistamycin to enzyme-associated template-primer.
1996 Dec 3
Inhibition of human immunodeficiency virus-1 reverse transcriptase by heme and synthetic heme analogs.
1996 Jan
The nucleoside analog-resistant E89G mutant of human immunodeficiency virus type 1 reverse transcriptase displays a broader cross-resistance that extends to nonnucleoside inhibitors.
1996 Jul
Anti-HIV-1 activity of thiadiazole derivatives: structure-activity relationship, reverse transcriptase inhibition, and lipophilicity.
1996 Jun
Antiviral activity and mechanism of action of calanolide A against the human immunodeficiency virus type-1.
1996 Nov
Comparative enzymatic study of HIV-1 reverse transcriptase resistant to 2',3'-dideoxynucleotide analogs using the single-nucleotide incorporation assay.
1997 Feb 4
Mechanism of inhibition of HIV-1 reverse transcriptase by 4'-Ethynyl-2-fluoro-2'-deoxyadenosine triphosphate, a translocation-defective reverse transcriptase inhibitor.
2009 Dec 18
The acyclic 2,4-diaminopyrimidine nucleoside phosphonate acts as a purine mimetic in HIV-1 reverse transcriptase DNA polymerization.
2010 Apr 16
The design and development of 2-aryl-2-hydroxy ethylamine substituted 1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamides as inhibitors of human cytomegalovirus polymerase.
2010 Mar 15
Patents
Substance Class Chemical
Created
by admin
on Fri Dec 15 17:59:28 GMT 2023
Edited
by admin
on Fri Dec 15 17:59:28 GMT 2023
Record UNII
6RGF96R053
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ZIDOVUDINE TRIPHOSPHATE
Common Name English
3'-AZIDO-3'-DEOXYTHYMIDINE TRIPHOSPHATE
Systematic Name English
AZTTP
Common Name English
3'-AZIDO-3'-DEOXYTHYMIDINE 5'-TRIPHOSPHATE
Systematic Name English
3'-AZIDOTHYMIDINE TRIPHOSPHATE
Systematic Name English
THYMIDINE 5'-(TETRAHYDROGEN TRIPHOSPHATE), 3'-AZIDO-3'-DEOXY-
Common Name English
AZIDOTHYMIDINE TRIPHOSPHATE
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID80239053
Created by admin on Fri Dec 15 17:59:28 GMT 2023 , Edited by admin on Fri Dec 15 17:59:28 GMT 2023
PRIMARY
CAS
92586-35-1
Created by admin on Fri Dec 15 17:59:28 GMT 2023 , Edited by admin on Fri Dec 15 17:59:28 GMT 2023
PRIMARY
FDA UNII
6RGF96R053
Created by admin on Fri Dec 15 17:59:28 GMT 2023 , Edited by admin on Fri Dec 15 17:59:28 GMT 2023
PRIMARY
PUBCHEM
72187
Created by admin on Fri Dec 15 17:59:28 GMT 2023 , Edited by admin on Fri Dec 15 17:59:28 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> METABOLITE ACTIVE
Related Record Type Details
ACTIVE MOIETY